MedPath

Tacrus

Tacrus

Approved
Approval ID

d0815b7a-46e5-0605-e053-2a95a90a78a8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 26, 2023

Manufacturers
FDA

Pella Pharmaceuticals Co. Ltd

DUNS: 562370925

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tacrolimus

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code82160-124
Product Classification
G
Generic Name
Tacrolimus
Product Specifications
Route of AdministrationTOPICAL
Effective DateDecember 26, 2023
FDA Product Classification

INGREDIENTS (1)

TACROLIMUSActive
Quantity: 30 mg in 30 g
Code: WM0HAQ4WNM
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tacrus - FDA Drug Approval Details